Annual Non Current Assets
$183.72 M
-$109.03 M-37.24%
31 December 2023
Summary:
Allogene Therapeutics annual long term assets is currently $183.72 million, with the most recent change of -$109.03 million (-37.24%) on 31 December 2023. During the last 3 years, it has fallen by -$198.98 million (-51.99%). ALLO annual non current assets is now -68.30% below its all-time high of $579.50 million, reached on 31 December 2021.ALLO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$284.70 M
+$94.95 M+50.04%
30 September 2024
Summary:
Allogene Therapeutics quarterly long term assets is currently $284.70 million, with the most recent change of +$94.95 million (+50.04%) on 30 September 2024. Over the past year, it has increased by +$45.83 million (+19.19%). ALLO quarterly non current assets is now -50.87% below its all-time high of $579.50 million, reached on 31 December 2021.ALLO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.2% | +19.2% |
| 3 y3 years | -52.0% | -50.6% |
| 5 y5 years | -39.9% | +53.2% |
ALLO Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.3% | at low | -50.9% | +55.0% |
| 5 y | 5 years | -68.3% | +6.1% | -50.9% | +64.3% |
| alltime | all time | -68.3% | -50.9% | +6114.9% |
Allogene Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $284.70 M(+50.0%) |
| June 2024 | - | $189.76 M(-0.6%) |
| Mar 2024 | - | $190.99 M(+4.0%) |
| Dec 2023 | $459.12 M(-13.2%) | $183.72 M(-23.1%) |
| Sept 2023 | - | $238.87 M(-11.2%) |
| June 2023 | - | $268.87 M(+1.3%) |
| Mar 2023 | - | $265.41 M(-9.3%) |
| Dec 2022 | $528.82 M(+12.2%) | $292.75 M(-8.1%) |
| Sept 2022 | - | $318.51 M(-26.7%) |
| June 2022 | - | $434.62 M(-12.2%) |
| Mar 2022 | - | $494.89 M(-14.6%) |
| Dec 2021 | $471.32 M | $579.50 M(+0.5%) |
| Sept 2021 | - | $576.39 M(+9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $524.55 M(+13.3%) |
| Mar 2021 | - | $462.98 M(+21.0%) |
| Dec 2020 | $845.13 M(+55.2%) | $382.70 M(+3.9%) |
| Sept 2020 | - | $368.44 M(+5.6%) |
| June 2020 | - | $348.97 M(+89.5%) |
| Mar 2020 | - | $184.11 M(+6.3%) |
| Dec 2019 | $544.58 M(+16.4%) | $173.23 M(-6.8%) |
| Sept 2019 | - | $185.79 M(-16.5%) |
| June 2019 | - | $222.46 M(-18.4%) |
| Mar 2019 | - | $272.74 M(-10.8%) |
| Dec 2018 | $467.98 M(>+9900.0%) | $305.87 M(+62.8%) |
| Sept 2018 | - | $187.88 M(+4001.3%) |
| June 2018 | - | $4.58 M |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual long term assets?
- What is the all time high annual non current assets for Allogene Therapeutics?
- What is Allogene Therapeutics annual non current assets year-on-year change?
- What is Allogene Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly non current assets year-on-year change?
What is Allogene Therapeutics annual long term assets?
The current annual non current assets of ALLO is $183.72 M
What is the all time high annual non current assets for Allogene Therapeutics?
Allogene Therapeutics all-time high annual long term assets is $579.50 M
What is Allogene Therapeutics annual non current assets year-on-year change?
Over the past year, ALLO annual long term assets has changed by -$109.03 M (-37.24%)
What is Allogene Therapeutics quarterly long term assets?
The current quarterly non current assets of ALLO is $284.70 M
What is the all time high quarterly non current assets for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly long term assets is $579.50 M
What is Allogene Therapeutics quarterly non current assets year-on-year change?
Over the past year, ALLO quarterly long term assets has changed by +$45.83 M (+19.19%)